Medicamen Biotech Limited — Others, 15-11-2024: Copy of Newspaper Publication

Medicamen Biotech Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended September 30, 2024. The un-audited results were published in the Financial Express and Jansatta, revealing important performance metrics. This update may provide insights into the company's operational efficiency and profitability, which could positively influence investor sentiment. Shareholders should monitor these results closely, as they may highlight growth opportunities or indicate potential risks, shaping future strategic decisions.